The researchers were studying the gene, called Brd2, which had not previously been linked to body energy balance. While complete absence of the gene was fatal, Dr Denis found that in mice where there had been a single, genetic change in the Brd2 gene, fortuitously reducing its expression, the mice became severely obese – but did not go on to develop Type 2 diabetes.
This result was very surprising because in both 'mice and men', chronic obesity commonly leads to Type 2 diabetes, with its life-threatening consequences, including heart disease, kidney and nerve damage, osteoporosis, blindness and circulation problems in the feet that can require amputation.
If the mice had been human their weight would be equivalent to approximately 270 kilograms (600 pounds); despite this, they exercised at the same levels as normal mice and, in comparison, lived for a surprisingly long time.
Obesity is linked to the development of Type 2 diabetes, and as obesity levels soar – it is predicted that there will be around 366 million diabetic individuals worldwide by 2030 – there is an urgent need for a much deeper biological understanding of the forces that link obesity and diabetes, in order to design new drugs and therapies for treatment.
However around 20 – 30% of the adult obese population remain relatively healthy despite their obesity. These are populations with a healthy metabolism but who are obese (MHO) while others are metabolically obese but are at a normal weight (MONW).
Dr Denis said, "Studies have shown that these individuals have a reduced 'inflammatory profile'. Inflammation caused by normal immune cells called macrophages leads to insulin resistance and Type 2 diabetes - this inflammation is typically seen in connection with obesity but it is the inflammation that is a trigger for diabetes, not the obesity itself. The mechanisms that explain this protection from diabetes are not well understood."
He went on to add, "Much like these protected obese humans, the Brd2-deficient mice have reduced inflammation of fat and never develop failure of the beta cells in the pancreas that is associated with Type 2 diabetes".
The researchers suggest several mechanisms by which the Brd2 gene mutation may protect against the development of diabetes.
These mice have impaired production of inflammation molecules that are normally seen in infections, but that also contribute to Type 2 diabetes. This impairment has the surprising benefit of protecting them from obesity-induced diabetes.
Commenting on the findings, Dr Denis said, "The strong influence of Brd2 levels on insulin production and action suggest that Brd2 is likely to be a promising target for diabetes treatment, but also imply that overactive Brd2 might cause diabetes. The ways in which Brd2 affects the immune system may also play a part in Type 1 diabetes, further studies to determine this are needed."
Further information available from Dianne Stilwell, e- mail email@example.com; tel +44 (0)20 8977 6510; mob +44 (0)7957 200214
Notes for Editors
1. "Brd2 disruption in mice causes severe obesity without Type 2 diabetes" by Fangnian Wang, Hongsheng Liu, Wanda P. Blanton, Anna Belkina, Nathan K. LeBrasseur and Gerald V. Denis, will be published in The Biochemical Journal (2009) Vol 425, part 1, pp 71-83 at www.biochemj.org on 14 December 2009
2. Dr Gerald Denis is at the Cancer Research Center, Boston University School of Medicine, Room K520, 72 East Concord Street, Boston MA 02118, USA. He can be contacted through Gina DiGravio, Media Relations Manager at Boston University School of Medicine Tel + 1 617-638-8480, e-mail firstname.lastname@example.org
3. Pictures to accompany the story are available from Dianne Stilwell or Gina DiGravio – contact details above; Picture caption as follows:
"Despite obesity, mice with the depleted Brd2 gene avoid Type 2 diabetes and several other life-threatening complications normally seen in human obesity. They may provide a model to discover the molecular pathways that could be used to protect obese humans."
4. This research was supported by a grant from the National Institutes of Health, specifically the National Institute of Diabetes, Digestive and Kidney Diseases.
5. The Biochemical Journal is published on behalf of the Biochemical Society by Portland Press Limited. Portland Press Limited is a not-for-profit publisher of journals, books and electronic resources in the cellular and molecular life sciences. It also delivers association management solutions for publishers, learned societies and membership-based organizations.
Gina DiGravio | EurekAlert!
‘Farming’ bacteria to boost growth in the oceans
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie
Calcium Induces Chronic Lung Infections
24.10.2016 | Universität Basel
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy